Richi LifeSciences shared a post on LinkedIn:
“As we gear up to start this fall’s edition of Richi LifeSciences, we’re delighted to introduce you to the selected companies who’ll join us in Boston from November 12th to 20th! This group represents the cutting edge of global innovation, and we can’t wait to see the impact they make.
Meet the brilliant companies ready to accelerate their growth in the US market:
- Acellera – A company dedicated to accelerating the transition to rational, computerized drug discovery via advanced simulations and machine learning.
- BDUK Therapeutics LTD. – A company developing a groundbreaking therapeutic delivery system for liver cancer, utilizing innovative porous microspheres.
- CCRP Therapeutics GmbH – A biopharmaceutical company focused on discovering novel small molecule drugs to treat cancer and end-organ damage caused by conditions like diabetes and hypertension.
- LYSINE BIOTECH PRIVATE LIMITED – A company pioneering the development of affordable, safe, and effective CAR T-cell therapies and biopharmaceuticals.
- Pharma in silica – A preclinical-stage company developing a well-tolerated chemotherapy treatment for various cancers using proprietary silica-made nanoparticles
We can’t wait to welcome you all to the world’s leading life sciences ecosystem, help you forge meaningful connections with investors and industry leaders, and equip you with the knowledge and tools to successfully scale and enter the U.S. market!”
More posts about Richi Foundation.